Three Good Things (3GT) - Intervention for Transitional Care Patients

NCT04970641 | Terminated

• 1 other identifier: 21-003878
• Study Type: interventional
• Target: 25
• Locations: 1 country
• Sites: 1

Brief Summary

Researchers are doing this research study to learn how the Three Good Things (3GT) Positive Psychology journaling activity affects symptoms of stress, depression, resilience, and happiness.

Conditions

Positive Thinking; Psychology, Positive; Resilience, Psychological

Outcome Measures

Primary Outcomes (1)

• Perceived Stress

  Change in subject perceived stress measured using the self-reported perceived stress scale (PSS). A 10-item questionnaire assessing individuals' appraisal of stress using a scale of 0=never, 4=very often.

  Baseline, 6 weeks

Secondary Outcomes (3)

• Subjective Depression

  Baseline, 6 weeks

• Subjective Happiness

  Baseline, 6 weeks

• Subjective Resilience

  Baseline, 6 weeks

Study Arms (2)

3GT journaling group

EXPERIMENTAL

Subjects will participate in the Three Good Things (3GT) Positive Psychology journaling activity daily for six weeks.

Behavioral: Three Good Things (3GT) Positive Psychology journaling activity

Non-journaling group

NO INTERVENTION

Subjects will not participate in the evening journal activity.

Interventions

Three Good Things (3GT) Positive Psychology journaling activity BEHAVIORAL

Evening journaling activity each day to reflect on three good things that the subject has noticed about their day's events.

3GT journaling group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Individuals ≥ 18 years of age.
• Current inpatient at the Mayo Clinic Health System Bloomer Hospital, Bloomer, Wisconsin (a Swing Bed Hospital as defined by the Center for Medicare and Medicaid Services (CMS)).
• Able to speak English.
• Able to answer questionnaires.

You may not qualify if:

• Individuals \< 18 years of age.
• Patient unwilling or unable to provide consent to participate in this research study.
• Patient under guardianship.
• As determined through self-report, patient in active psychosis, active suicidal ideation, active substance abuse meeting criteria for substance use disorders except for nicotine (the exception is patients with a history of substance abuse that have been in remission for at least one full year).
• Patient diagnosed with obsessive-compulsive disorder, active panic disorder with agoraphobia or other phobic disorder, active Post Traumatic Stress Disorder, or active severe personality disorders.
• Patient with previous participation in this study.

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic Health System Bloomer Hospital

Bloomer, Wisconsin, 54724, United States

Location

Study Officials

• Lori M Miller, MAOM, RN

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: July 19, 2021
• First Posted: July 21, 2021
• Study Start: September 30, 2021
• Primary Completion: December 1, 2023
• Study Completion: December 1, 2023
• Last Updated: April 10, 2024

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)